Home » Stocks » Atrion Corporation

Atrion Corporation (ATRI)

Stock Price: $656.10 USD 11.50 (1.78%)
Updated Aug 12, 2020 4:00 PM EDT - Market closed
After-hours: $652.01 -4.09 (-0.62%) Aug 12, 4:00 PM

Stock Price Chart

Key Info

Market Cap 1.20B
Revenue (ttm) 154.91M
Net Income (ttm) 35.16M
Shares Out 1.83M
EPS (ttm) 18.95
PE Ratio 34.62
Forward PE n/a
Dividend $6.20
Dividend Yield 0.94%

Stock Quote

Trading Day Aug 12, 2020
Last Price $656.10
Previous Close $644.60
Change ($) 11.50
Change (%) 1.78%
Day's Open 652.36
Day's Range 645.01 - 673.45
Day's Volume 3,293
52-Week Range 579.00 - 846.15

More Stats

Market Cap 1.20B
Enterprise Value 1.17B
Earnings Date (est) n/a
Ex-Dividend Date Jun 12, 2020
Shares Outstanding 1.83M
Float 1.40M
EPS (basic) 19
EPS (diluted) 18.95
FCF / Share 10.08
Dividend $6.20
Dividend Yield 0.94%
Earnings Yield 2.89%
FCF Yield 1.54%
Payout Ratio n/a
Shares Short 80,265
Short Ratio 15.26
Short % of Float 5.95%
Beta 0.15
PE Ratio 34.62
Forward PE n/a
P/FCF Ratio 64.91
PS Ratio 7.75
PB Ratio 5.03
Revenue 154.91M
Operating Income 40.29M
Net Income 35.16M
Free Cash Flow 18.49M
Net Cash 30.67M
Net Cash / Share 16.77
Gross Margin 45.63%
Operating Margin 26.01%
Profit Margin 22.70%
FCF Margin 11.93%
ROA 9.89%
ROE 15.33%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$300.00*
Low
300
Current: $656.10
High
300
Target: 300.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue155152147143146141132119118109
Revenue Growth1.72%3.99%2.17%-1.54%3.53%6.64%10.86%1.15%8.41%-
Gross Profit70.6971.7870.7567.6370.9868.5263.0656.1460.0150.91
Operating Income40.5341.7141.2739.1342.5140.8237.9433.6338.1730.98
Net Income36.7634.2636.5927.5828.9327.8126.5823.6326.0420.95
Shares Outstanding1.861.851.851.821.851.962.012.022.022.02
Earnings Per Share19.7318.4419.7114.8515.4714.0813.1811.6612.8210.32
EPS Growth7%-6.44%32.73%-4.01%9.87%6.83%13.04%-9.05%24.22%-
Dividend Per Share5.805.104.503.903.302.782.4012.101.8210.56
Dividend Growth13.73%13.33%15.38%18.18%18.71%15.83%-80.17%564.84%-82.77%-
Operating Cash Flow42.4743.2447.0437.4040.4331.2236.5829.3731.5431.06
Capital Expenditures-20.45-17.51-9.68-10.64-9.32-12.67-7.50-10.35-12.00-4.29
Free Cash Flow22.0225.7337.3626.7631.1018.5529.0719.0219.5426.77
Cash & Equivalents68.8168.4465.6044.1028.3923.8646.9116.1844.8721.39
Net Cash / Debt68.8168.4465.6044.1028.3923.8646.9116.1844.8721.39
Assets262231204182164172172156162135
Liabilities24.1620.4519.3918.9520.2421.9423.0720.9823.3818.04
Book Value238211184163144150149135139117
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Atrion Corporation
Country United States
Employees 616
CEO David A. Battat

Stock Information

Ticker Symbol ATRI
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: ATRI

Description

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Germany, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 Myocardial Protection System that delivers fluids and medications, mixes critical drugs, and controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.